Mass Spectrometry Hub

While mass spectrometry (mass spec) is a common basic research tool, over the last decade, the technology has become more widely adopted for use in diagnostic testing in the clinical setting. With new generations of technologies coming to market, clinical labs utilize mass spec in routine testing to improve the sensitivity and specificity of diagnostic testing, as e.g. disease screening or therapeutic drug monitoring that can provide labs with accurate results more rapidly than conventional mass spec solutions.

 

The technology behind:  

Mass spec is an analytical technique that measures the mass-to-charge ratio (m/z) of molecules, such as e.g. small molecules and drugs, in a sample. 

  • Mass spec offers better sensitivity and specificity for identifying molecular structure of compounds compared to traditional methods.

  • By adopting mass spec automation, lab leaders can help improve patient management in multiple care areas, including endocrinological diseases and  therapeutic drug monitoring

 

 

In the following tabs you will find publications and congress material discussing the latest developments in Mass Spectrometry. In particular, data on therapeutic drug monitoring (TDM), vitamin D and steroids among others are presented. Please note that the discussed results derive from medical educational events, studies and publications with Roche involvement. In the future scientific content on drugs of abuse testing (DAT) and other analytes will be included.

 

 

Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

Not a healthcare professional? Browse:

This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.